General Hospital Corporation d/b/a Massachusetts General Hospital donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

We do not have any donee information for the donee General Hospital Corporation d/b/a Massachusetts General Hospital in our system.

Donation amounts by donor and year for donee General Hospital Corporation d/b/a Massachusetts General Hospital

Donor Total 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Bill and Melinda Gates Foundation (filter this donee) 89,492,098.69 2,549,022.00 18,427,236.00 8,389,266.69 8,890,722.00 2,878,092.00 13,016,460.00 9,338,749.00 100,000.00 5,217,426.00 100,000.00 20,585,125.00
Total 89,492,098.69 2,549,022.00 18,427,236.00 8,389,266.69 8,890,722.00 2,878,092.00 13,016,460.00 9,338,749.00 100,000.00 5,217,426.00 100,000.00 20,585,125.00

Full list of donations in reverse chronological order (48 donations)

DonorAmount (current USD)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation1,962,033.002017-10-23Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to identify the potential causal role of antibodies in MTB control in vivo in an effort to guide future vaccine design; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation750,001.002017-08-11Global health/Reproductive health carehttps://iatiregistry.org/publisher/bmgf-- to support an evaluation of the behavioral and contextual barriers to optimal usage of a Uterine Balloon Tamponade (UBT) package, identify the optimal levers for uptake acceleration, and implement an updated the training package; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-163,012.002017-02-07Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support a project designed to define the baseline status of the immune system immediately before, and during the earliest events in HIV infection, and to define events leading to the development of effective protective immunity; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,586,883.002016-12-21Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop a novel set of tools to expedite the development of safe and effective clustered regularly interspaced short palindromic repeats nuclease-based gene drive solutions for genetic control of human malaria vector Anopheles gambiae; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,984,509.002016-11-30Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to identify unique immune responses in individuals who resist tuberculosis infection to guide future vaccine design; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,277,895.002016-11-30Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to identify the potential causal role of antibodies in MTB control in vivo in an effort to guide future vaccine design; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002016-10-20Family planninghttps://iatiregistry.org/publisher/bmgf-- to develop lower cost and more effective female contraceptives by using their cell-based screening platform to identify compounds that target one of the earliest stages of follicle development in the ovary; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,848,947.002016-08-01Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to define cell immune responses induced by hyperacute and chronic HIV infection to inform vaccine design; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,380,465.002016-07-20Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to plan for the elimination of cholera transmission in Haiti via the implementation of a package of oral cholera vaccine complemented by water interventions in a specific catchment area with research to document best practices; Aid type: Project-type interventions. Affected countries: Haiti.
Bill and Melinda Gates Foundation600,000.002016-06-22Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to enable the rapid development of vaccines for HIV and TB. Global Health Innovation Partnership. Investment start date: 6/22/2015 to end date: 5/31/2020. Grantee name: General Hospital Corporation d/b/a Massachusetts General Hospital; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation600,000.002016-06-22Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to enable the rapid development of vaccines for HIV and TB. Global Health Innovation Partnership. Investment start date: 6/22/2015 to end date: 5/31/2020. Grantee name: General Hospital Corporation d/b/a Massachusetts General Hospital; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,048,537.002016-03-21Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support a genetic approach to optimizing the antigenicity of HIV-1 envelope immunogens; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,996,999.002015-11-23Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to test the potential use of adjuvant anti-angiogenic and anti-fibrotic treatment to improve drug delivery and increase the efficacy of existing tuberculosis drugs, potentially shortening treatment duration, and thereby improving and simplifying tuberculo; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,758,812.002015-11-12Nutrition/basic nutritionhttps://iatiregistry.org/publisher/bmgf-- to provide a minimally invasive means for obtaining detailed information on infantile intestinal tissue that is needed for the development of effective environmental enteropathy (EE) interventions; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002015-10-27Nutrition/basic nutritionhttps://iatiregistry.org/publisher/bmgf-- to better treat environmental enteropathy and other potentially deadly childhood diseases caused by enteric pathogens such as Escherichia coli by isolating and/or engineering selective bacteriophage (viruses that infect bacteria); Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation750,000.002015-06-22Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to enable the rapid development of vaccines for HIV and TB. Global Health Innovation Partnership. Investment start date: 6/22/2015 to end date: 5/31/2020. Grantee name: General Hospital Corporation d/b/a Massachusetts General Hospital; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation750,000.002015-06-22Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to enable the rapid development of vaccines for HIV and TB. Global Health Innovation Partnership. Investment start date: 6/22/2015 to end date: 5/31/2020. Grantee name: General Hospital Corporation d/b/a Massachusetts General Hospital; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,033,649.002015-05-19Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop an ultra-rapid freezing protocol using quartz microcapillary tubes in order to provide a more immediate cryopreservation method that can be quickly delivered to the malaria community; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-193.312015-05-08Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop a new class of potentially effective antimalarial drugs by evaluating inhibitors of tRNA-synthetases, which are enzymes that are essential for survival of the malaria parasite; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation-20,000.002015-04-21Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to prevent HIV transmission through improving adherence to pre-exposure prophylaxis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation20,000.002015-04-21Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support a study that will determine the need and nature of adherence interventions that may be required to expand treatment to people with early HIV disease as an essential step to reducing HIV incidence; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation42,487.062015-01-23Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support a project designed to define the baseline status of the immune system immediately before, and during the earliest events in HIV infection, and to define events leading to the development of effective protective immunity; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-42,487.062015-01-23Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to use population based studies of immune responses, viral evolution and host genetics to achieve effective immunogen design for a global HIV vaccine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,109,314.002014-11-18Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to apply and further develop a set of tools to define vaccine signatures associated with protection from infection to guide future vaccine design; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,767,989.002014-10-30Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support a study that will determine the need and nature of adherence interventions that may be required to expand treatment to people with early HIV disease as an essential step to reducing HIV incidence; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation100,000.002014-10-21Global health/basic health carehttps://iatiregistry.org/publisher/bmgf-- to improve detection of abnormal brain development in low-income settings by using a non-invasive handheld optical coherence tomography device to measure the thickness of the retina over the first five years of life; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation652,050.002014-08-13Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support a project designed to define the baseline status of the immune system immediately before, and during the earliest events in HIV infection, and to define events leading to the development of effective protective immunity; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation78,246.002014-06-11Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to prevent HIV transmission through improving adherence to pre-exposure prophylaxis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation183,123.002014-01-28Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support a genetic approach to optimizing the antigenicity of HIV-1 envelope immunogens; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,436,233.002013-11-14Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support a genetic approach to optimizing the antigenicity of HIV-1 envelope immunogens; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation341,859.002013-05-13Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to define, induce, and evaluate the protection afforded by potent innate immune-recruiting antibodies..; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002013-04-22Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop a new class of potentially effective antimalarial drugs by evaluating inhibitors of tRNA-synthetases, which are enzymes that are essential for survival of the malaria parasite; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation12,916,460.002012-11-01Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support a project designed to define the baseline status of the immune system immediately before, and during the earliest events in HIV infection, and to define events leading to the development of effective protective immunity; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002012-10-19Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop a microfluidic device that can be used to screen anti-malarial drugs for the development of drug resistance with single cell resolution.; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation974,995.002011-11-11Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to research the impact of antiangiogenic treatment on the efficacy of treatment for TB - Exploring vascular homeostatis in TB persistence; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation7,963,754.002011-10-31Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to define, induce, and evaluate the protection afforded by potent innate immune-recruiting antibodies..; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002011-10-26Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a cell phone system that can aid in vaccination campaigns in developing countries.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002011-10-20Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to test whether pre-treating the skin at the site of vaccination with an infrared laser light to stimulate antigen-presenting cells will result in a stronger immune response to the polio vaccination.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002011-04-21Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to identify and characterize individual cells latently infected with HIV for use as markers to target and eliminate HIV-infected cells.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002011-04-21Global health/basic health carehttps://iatiregistry.org/publisher/bmgf-- to develop a portable, low-cost mobile-phone-based near-infrared camera for monitoring brain injury in neonates.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002010-04-16Global health/Medical researchhttps://iatiregistry.org/publisher/bmgf-- to attempt to reverse engineer in vitro G-protein coupled receptors (GPCRs), which usually are used by the human body to sense light, odors, tastes and hormones, to detect selected parasite biomarkers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation542,398.002009-10-21Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to research the impact of antiangiogenic treatment on the efficacy of treatment for TB - Exploring vascular homeostatis in TB persistence; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002009-10-05Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to investigate whether using oral supplementation of intestinal alkaline phosphatase (IAP), will prevent or cure infection by pathogenic bacteria, leading to a universal strategy against diarrheal diseases.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,475,028.002009-08-01Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to prevent HIV transmission through improving adherence to pre-exposure prophylaxis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002009-02-26Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to test whether injection of a vaccine into laser-exposed skin can significantly enhance immune responses stimulated by the vaccine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002008-09-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to design a conjugate which will attach to the GP63 enzyme of the Leishmania parasite, creating a lightactivatable, non-toxic chemical therapy that will be activated by a light source, killing the parasite but leaving surrounding cells intact; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-2,166,651.002007-12-03Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to use population based studies of immune responses, viral evolution and host genetics to achieve effective immunogen design for a global HIV vaccine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation22,751,776.002007-11-21Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to use population based studies of immune responses, viral evolution and host genetics to achieve effective immunogen design for a global HIV vaccine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.